Proposition B definition

Proposition B means the San Francisco County Transportation Authority Authorization Ordinance adopted and approved by the voters on November 7, 1989 adding Article 14 of the Business and Tax Regulations Code of the City and County of San Francisco Municipal Code.
Sample 1Sample 2Sample 3

Examples of Proposition B in a sentence

  • Limiting the Defined Benefit Plan to employees hired before July 20, 2012 is subject to the reopener provisions on Proposition B in Article 31, Section E.

  • This paragraph is subject to the reopener provisions on Proposition B in Article 31, Section E.

  • The parties acknowledge that, in January 2012, MEA filed an unfair labor practice charge with the California Public Employment Relations Board (PERB) related to Proposition B, and that three other recognized employee organizations (REOs) filed similar charges which were consolidated with MEA’s case (hereinafter “PERB litigation”).

  • The three official ballot proponents for Proposition B (Xxxxx Xxxxxx, X.

  • This judgment includes a writ in quo warranto issued to the City and its City Council directing that the Proposition B charter amendments, which took effect on July 20, 2012, be removed from the City Charter and for the City to conform the San Diego Municipal Code and any other related enactments accordingly.

  • The reconstruction of Montfort Drive was approved by voters as part of Proposition B in the 2019 bond election.

  • Once a court of competent jurisdiction issues a final order or decision declaring the Proposition B charter amendments to be either invalid or valid, in whole or in part, the parties to this MOU agree to reopen negotiations on that provision or aspect of Proposition B declared to be unlawful or invalid, and, to the extent declared valid, on any provisions or aspects of Proposition B not yet implemented.

  • Xxxx and Xxxxxxx Xxxxxxxx) intervened in the action to oppose the invalidation of the Proposition B charter amendments and, at the time this MOU was adopted, the case remains pending.

  • The Authority shall not permit the final maturity date of any Senior Lien Debt, Parity Debt or Subordinate Obligations to be beyond the earliest of (i) the expiration date of the applicable provisions of Proposition B and Proposition K which permit the use of the Sales Tax Revenues to repay Senior Lien Debt, Parity Debt or Subordinate Obligationsand(ii) March 1, 2034.

  • In furtherance of PERB’s Court-approved Remedial orders, MEA and the other three REOs sought leave from the State Attorney General to xxx the City in quo warranto to seek an order invalidating the Proposition B charter amendments which became effective on July 20, 2012.

Related to Proposition B

  • Ballot proposition means a question, issue, or proposal that is submitted to voters

  • conformity assessment means the process demonstrating whether the requirements of this Regulation relating to a device have been fulfilled;

  • Site evaluation means a comprehensive analysis of soil and site conditions for an OWTS.

  • Phase III means Phase I (or Phase I/II), Phase II (or Phase II/III) and Phase III clinical trials, respectively, in each case as prescribed by applicable FDA IND Regulations, or any corresponding foreign statutes, rules or regulations.

  • Data Protection Impact Assessment means an assessment by the Controller of the impact of the envisaged processing on the protection of Personal Data.

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Project Proponent means the individual or organization that has overall control and responsibility for the Project, or an individual or organization that together with others, each of which is also a Project Proponent, has overall control or responsibility for the Project. The entity(s) that can demonstrate Project Ownership in respect of the Project. For the avoidance of doubt where an individual executes this Representation in their capacity as an authorized office holder of the company who is the Project Proponent, this Representation is made by the company, not the authorized office holder;

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • Remediation waste management site means a facility where an owner or operator is or will be treating, storing or disposing of hazardous remediation wastes. A remediation waste management site is not a facility that is subject to corrective action under § 264.101 of this regulation, but is subject to corrective action requirements if the site is located in such a facility.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Cluster development means a contiguous cluster or

  • Approved laboratory means a laboratory that is listed in the national conference of interstate milk shipments list of sanitation compliance and enforcement ratings distributed by the United States food and drug administration and as approved by the director.

  • Phase I means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.

  • Risk assessment means a programme to determine any risk associated with any hazard at a construction site, in order to identify the steps needed to be taken to remove, reduce or control such hazard;

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase I assessment as described in, and meeting the criteria of, (i) Chapter 5 of the FNMA Multifamily Guide or any successor provisions covering the same subject matter in the case of a Specially Serviced Mortgage Loan as to which the related Mortgaged Property is multifamily property or (ii) the American Society for Testing and Materials in the case of Specially Serviced Mortgage Loan as to which the related Mortgaged Property is not multifamily property.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Participating Prescription Drug Provider means an independent retail Pharmacy, chain of retail Pharmacies, mail-order Pharmacy or specialty drug Pharmacy which has entered into an agreement to provide pharmaceutical services to participants in the benefit program. A retail Participating Pharmacy may or may not be a select Participating Pharmacy as that term is used in the Vaccinations Obtained Through Participating Pharmacies section.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Corrective Measure The contractor shall repair any deficiencies to meet the performance guideline within warranty period.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Preliminary assessment means the first phase in the process of identifying areas of concern and determining whether contaminants are or were present at a site or have migrated or are migrating from a site, and shall include the initial search for and evaluation of, existing site specific operational and environmental information, both current and historic, to determine if further investigation concerning the documented, alleged, suspected or latent discharge of any contaminant is required. The evaluation of historic information shall be conducted from 1932 to the present, except that the department may require the search for and evaluation of additional information relating to ownership and use of the site prior to 1932 if such information is available through diligent inquiry of the public records.

  • Waste Framework Directive or “WFD” means Waste Framework Directive 2008/98/EC of the European Parliament and of the Council on waste

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.